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ABSTRACT
Ethanol exposure produces alterations in GABAergic signaling
that are associated with dependence and withdrawal. Previ-
ously, we demonstrated that ethanol-induced protein kinase C
(PKC) g signaling selectively contributes to changes in GABAA
a1 synaptic receptor activity and surface expression. Here, we
demonstrate that protein kinase A (PKA) exerts opposing effects
on GABAA receptor adaptations during brief ethanol exposure.
Cerebral cortical neurons from day 0–1 rat pups were tested
after 18 days in culture. Receptor trafficking was assessed by
Western blot analysis, and functional changes were measured
using whole-cell patch-clamp recordings of evoked and mini-
ature inhibitory postsynaptic current (mIPSC) responses. One-
hour ethanol exposure increasedmembrane-associated PKC and
PKA, but steady-state GABAA a1 subunit levels were maintained.
Activation of PKA by Sp-adenosine 39,59-cyclic monophospho-
thioate triethylamine alone increased GABAA a1 subunit surface
expression and zolpidempotentiation of GABA responses, whereas
coexposure of ethanol with the PKA inhibitor Rp-adenosine
39,59-cyclic monophosphothioate triethylamine decreased a1
subunit expression and zolpidem responses. Exposure to the
PKC inhibitor calphostin-C with ethanol mimicked the effect
of direct PKA activation. The effects of PKA modulation on
mIPSC decay t were consistent with its effects on GABA currents
evoked in the presence of zolpidem. Overall, the results suggest
that PKA acts in opposition to PKC on a1-containing GABAA
receptors, mediating the GABAergic effects of ethanol exposure,
and may provide an important target for the treatment of alcohol
dependence/withdrawal.
Introduction
Ethanol elicits a number of adaptations in GABAergic
signaling following both acute and chronic exposure. Evidence
suggests that acute ethanol intoxication increases overall
GABAergic inhibition, whereas chronic ethanol leads to def-
icits in GABA functioning [reviewed in Kumar et al. (2004,
2009)]. Numerous studies suggest that the major changes
associated with GABAergic deficits following chronic ethanol
exposure include a decrease in surface expression of GABAA
receptor a1 subunits in both the cerebral cortex (Devaud
et al., 1997; Kumar et al., 2003) and hippocampus (Cagetti
et al., 2003; Liang et al., 2004, 2006, 2007). Chronic ethanol
exposure produces a withdrawal syndrome upon discontinu-
ation of ethanol that is mimicked, in part, by genetic deletion
of a1 subunits in mice that were never exposed to ethanol.
This suggests that the loss of GABAA a1 receptor surface
expression is involved in tremor and enhanced seizure
susceptibility associated with ethanol dependence (Kralic
et al., 2002, 2005). Additionally, similar alterations in GABAA
a1 subunit levels are found in other disorders, including
models of epilepsy and benzodiazepine tolerance (Chen et al.,
1999; Zeng and Tietz, 1999; Gonzalez and Brooks-Kayal,
2011). Therefore, a better understanding of GABAA receptor
regulation following ethanol exposure may provide both
valuable insights into the general mechanism of GABAA
receptor regulation as well as potential therapeutic targets
for pathologies linked to these disorders.
Recently, we and others have shown that GABAA receptor
adaptations to ethanol are recapitulated in vitro following
a brief ethanol exposure in cultured cortical and hippocampal
neurons (Kumar et al., 2010; Shen et al., 2011; Werner et al.,
2011). The effect of ethanol is dependent upon the selective
activation of protein kinase C (PKC) g to induce the inter-
nalization of GABAA a1 subunits (Kumar et al., 2010), con-
sistent with the ability of ethanol to activate PKCg and reduce
GABAA a1 subunit surface expression in vivo. However, there
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is a mismatch between the time-dependent effects of ethanol
on PKCg and GABAA a1 receptors, suggesting the involvement
of other mechanisms (Kumar et al., 2010).
Ethanol has long been known to directly activate protein
kinase A (PKA) (Dohrman et al., 1996). In vivo studies impli-
cate PKA as playing a role in the behavioral effects of ethanol
(Thiele et al., 2000; Pandey et al., 2003; Lai et al., 2007).
Additionally, PKA has been shown to directly phosphorylate
and modulate GABAA receptor activity (Ives et al., 2002;
Brandon et al., 2003). Recently, we found that ethanol dose-
and time-dependently increased PKA membrane levels in rat
cerebral cortex, which corresponded to increased GABAA a1
subunit expression (Kumar et al., 2012). The precise physi-
ological consequences of ethanol regulation of GABAergic
inhibition via PKA, however, are unclear. As recent studies
from our laboratory suggest that both PKC and PKA acti-
vation may influence GABAA receptor activity during eth-
anol exposure, we investigated the dualistic role of PKA and
PKC in modulating the actions of ethanol on GABAA receptor
a1 subunit expression and function in cortical cultured
neurons.
Materials and Methods
Cultured Cerebral Cortical Neurons. All experiments were
conducted in accordance with guidelines from the National Institutes
of Health and Institutional Animal Care and Use Committee at the
University of North Carolina. Cultured cerebral cortical neurons were
isolated as described elsewhere (Kumar et al., 2010). Briefly, mixed-
sex rat pups from Sprague-Dawley breeding pairs (Harlan, Indian-
apolis, IN) were decapitated on postnatal day 0–1. Brains were
rapidly dissected and the cerebral cortices were isolated. Cortical
halves were minced into fine pieces, and tissue was incubated in CO2-
independent media containing papain (50 U/ml) (Worthington, Lake-
wood, NJ) and L-cysteine and DNase (both from Sigma-Aldrich, St.
Louis, MO) for 30 minutes at 37°C. Tissue pieces were gently washed
followed by gentle trituration in Dulbecco’s modified Eagle’s medium
(Gibco, Grand Island, NY) containing 10% horse serum, penicillin-
streptomycin, and DNase. Cells used for biochemistry were plated
onto poly-D-lysine–coated flasks, while cells used for electrophysiology
were plated onto poly-D-lysine–coated cover slips in 12-well plates.
Cells were maintained in a 5% CO2 humidified incubator. After day 3,
cells were fed with serum-free medium containing B27 and penicillin-
streptomycin (10,000 U/ml; final concentration, 50 U per flask). Media
were changed twice per week with nomore than one-third of the media
being removed during exchanges. For all experiments, penicillin-
streptomycin was removed from cultures on day 14 to prevent
interactions with GABAA receptors. Cultures were maintained for
at least 17 days before conducting experiments, as prior studies
determined that GABAA receptor expression was stable between
15 and 19 days in vitro.
Ethanol and Drug Exposure. Cultured cells were exposed to 50
mM ethanol and placed in a plastic chamber within the incubator. A
beaker of water with 50 mM ethanol was used to maintain stable
ethanol concentrations in the chamber. Control cells were exposed to
an equivalent amount of water and placed in a vapor chamber with
a beaker containing water. Cells were exposed to ethanol for various
times (0–60 minutes). To examine PKA involvement, the PKA acti-
vator Sp-adenosine 39,59-cyclic monophosphothioate triethylamine
(Sp-cAMP) (70 mM) and the PKA inhibitor Rp-adenosine 39,59-cyclic
monophosphothioate triethylamine (Rp-cAMP) (50 mM) were added
to the cell media. These doses were chosen based on previous studies
(Zhang and Pandey, 2003). To examine PKC involvement, the PKC
inhibitor calphostin-C (CalC) (0.3 mM in 0.1% dimethyl sulfoxide,
final concentrations) was used as previously described (Kumar et al.,
2010).
P2 Fractionation and Biotinylation. After experiments, the
reactions were stopped by placing the flasks on ice. Cells were washed
with cold phosphate-buffered saline (PBS), scraped, centrifuged at
1000g for 18 minutes, and stored at 280°C until fractionation. Cell
pellets were homogenized in 0.32 M sucrose and centrifuged at 1000g
for 10 minutes. The supernatant was then centrifuged twice for 30
minutes at 12,000g. The final pellet was resuspended in PBS. Protein
concentrations for the isolated P2 fraction were made using the
bicinchoninic acid protein assay kit (ThermoFisher Scientific,Waltham,
MA). Biotinylation experiments were performed as previously de-
scribed (Kumar et al., 2010). Briefly, cells were washed twice with ice-
cold PBS, followed by addition of sulfosuccinimidyl 2-(biotinamido)-
ethyl-1,3-dithiopropionate diluted in PBS, and incubated for 30minutes
at 4°C. Unbound biotin was inactivated using a quenching solution.
Cells were scraped and spun three times at 500g in Tris-buffered
saline. Biotin-labeled (surface) and flow-through (cytosolic) proteins
were separated using NeutrAvidin slurry (Thermo Fisher Scientific).
Biotinylated proteins were eluted from the beads by incubation for 60
minutes at 22°C in Laemmli sodium dodecyl sulfate polyacrylamide
gel electrophoresis sample buffer. Samples were then subjected to gel
electrophoresis and Western blotting.
Western Blot Analysis. GABAA receptor a1 subunits, PKA
subunits, and PKC isoforms were analyzed by Western blotting as
described elsewhere (Kumar et al., 2010). Protein samples were sub-
jected to sodium dodecyl sulfate polyacrylamide gel electrophoresis
using Novex Tris-Glycine (8–16%) gels and transferred to polyviny-
lidene difluoride membranes (Invitrogen, Carlsbad, CA). Membranes
were probed with GABAA receptor a1 subunit (Millipore, Billerica,
MA) or PKA RIIa, RIIb, or PKCg (BD Biosciences, Franklin Lakes,
NJ) antibodies. Blots were then exposed to an antibody for b-actin for
normalization. Proteins were detected with enhanced chemilumine-
sence (GE Healthcare, Amersham, UK). Membranes were exposed
to film under nonsaturating conditions. Densitometric analysis was
conducted using NIH Image 1.57 (Bethesda, MD). Comparisons were
made within blots and expressed as % averaged control values.
Statistics were conducted using analysis of variance (ANOVA) or
Student’s t test.
Electrophysiology. Whole-cell voltage clamp recordings were
used to assess evoked currents and miniature inhibitory postsynaptic
currents (mIPSCs). Electrodes were pulled using a PP-830 (Narishige,
Tokyo, Japan) and fire-polished to a resistance of 2–3 MV. In-
tracellular solution contained 150 mM KCl, 3.1 mM MgCl2, 15 mM
HEPES, 5 mM KATP, 5 mM EGTA, and 15 mM phosphocreatine,
adjusted to pH 7.4 with KOH, while extracellular solution contained
145 mMNaCl, 5 mMKCl, 10 mMHEPES, 2 mM CaCl2, 1 mMMgCl2,
5 mM sucrose, and 10mM glucose, adjusted to pH 7.4 with NaOH. For
mIPSC recordings, the external solution also contained 6-cyno-7-
nitroquinoxaline-2,3-dione (10 mM) (Sigma-Aldrich), D-2-amino-5-
phosphonopentanoic acid (40 mM) (Tocris Bioscience, Bristol, UK),
and tetrodotoxin (1 mM) (Sigma-Aldrich). Membrane potential was
held at 260 mV, and currents were recorded with an Axopatch ID
(Axon Instruments, Union City, CA) amplifier. Data were collected
using Clampex software (Axon Instruments). Drugs were diluted in
the extracellular solution and applied using a U-tube apparatus.
Zolpidem (100 nM) was coapplied with GABA (1 or 10 mM) to observe
potentiation. Potentiation by zolpidem is expressed as the current in
response to (GABA 1 zolpidem/GABA alone  100). Dose-response
curves were generated from GABA-evoked responses at 1, 3, 10, 30,
100 mM, and 1 mM GABA. Current amplitudes were normalized to
the averaged control current response to 1 mM GABA and fit using
GraphPad Prism software (GraphPad Software, La Jolla, CA) with
the sigmoidal dose-response equation:
Y5min1 ðmax2minÞ=½11 10∧ðLogEC50 2XÞ
mIPSCs were analyzed using the Mini-Analysis software (version
5.6.4; Synaptosoft, Decatur, GA). mIPSCs were recorded for a mini-
mum of 3 minutes. Minimum threshold detection was set to 5 pA.
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Frequency and amplitude were determined using automatic detection
of each recording. To assess mIPSC kinetics, the recording trace was
visually inspected and only events with a stable baseline, sharp rising
phase, and single peak were used to negate artifacts due to event
summation. Only recordings with a minimum of 25 events fitting
these criteria were analyzed. Decay time constants were obtained by
using a double exponential fit for the average of the mIPSCs in
a single recording. Numerical data are presented as mean 6 S.E.M.
Statistics were conducted using ANOVA or Student’s t test.
Results
PKA Activation by Ethanol Modulates GABAA Re-
ceptor Trafficking and Activity. Cultured cerebral corti-
cal neurons were exposed to ethanol (50 mM) for 1 hour to test
for its effects on membrane expression of GABAA a1 subunit
and protein kinase levels (Fig. 1). Whereas 4-hour ethanol
exposure produces a decrease in GABAA a1 levels (Kumar
et al., 2010), no effects on this subunit are observed at the
1-hour time point (Fig. 1A). However, 1-hour ethanol exposure
produced a significant increase in the abundance of both
PKCg (78.1% 6 21.0%; n 5 7; P , 0.05, Student’s t test)
(Fig. 1B) and the PKA regulatory subunits RIIa (35.5% 6
12.7%; n 5 6; P , 0.05, Student’s t test) (Fig. 1C) and RIIb
(36.4% 6 11.1%; n 5 6; P , 0.05, Student’s t test) (Fig. 1D) in
the P2 fraction. Table 1 provides a comparison of the GABAA
a1 and protein kinase trafficking changes induced by 1-hour
and 4-hour ethanol exposure in cerebral cortical neurons.
Whereas GABAA a1 membrane levels are unchanged at 1
hour and decreased following 4-hour ethanol, PKCg levels are
elevated at both time points. Conversely, whereas PKA RIIa
and RIIb are elevated at the 1-hour time point, PKA levels
return to baseline after 4-hour ethanol (Table 1).
To determine the effects of ethanol that are mediated by
PKA,GABAA receptor subunit levels were assessed after either
direct activation of PKA or ethanol exposure in the presence of
a PKA inhibitor. Additionally, whole-cell patch-clamp record-
ings were used to measure functional changes in GABAA recep-
tor electrophysiological responses. GABA (1–1000mM) responses
were first determined, and then zolpidem (100 nM) enhance-
ment of GABA (10 mM) responses was used as a pharmaco-
logical indicator for altered synaptic GABAA a1–containing
receptor activity (Liang et al., 2004; Kumar et al., 2010).
Currents evoked by GABA alone were compared with currents
evoked by coapplication of GABA 1 zolpidem to measure
percent potentiation.
Exposure to the PKA activator Sp-cAMP (50 mM) for 1 hour
produced a significant increase in GABAA a1 subunits rela-
tive to control values in the P2 fraction (58.4%6 13.7%; n5 7;
P , 0.05, Student’s t test) (Fig. 2A), with a corresponding
increase in surface biotinylated protein (50.48% 6 18.45%;
n5 5; P , 0.05, Student’s t test) (Fig. 2B) and decrease in the
cytosolic fraction (54.03%6 10.74%; n5 5; P, 0.05, Student’s
t test) (Fig. 2C). Sp-cAMP exposure had no effect on the EC50
or amplitude of GABA-evoked responses (Fig. 2D) or whole-
cell GABA-evoked current amplitude at the dose used to test
zolpidem enhancement of GABA responses (Fig. 2E). Sp-cAMP
exposure did, however, increase zolpidem potentiation of
GABA responses by 78.1%6 9.4% (n5 6 per group; Student’s t
test, P , 0.05) (Fig. 2, F and G) compared with control cells.
Currents evoked over the course of 1 hour during Sp-cAMP
Fig. 1. One-hour ethanol (EtOH) (50 mM) alters expres-
sion of protein kinase subunits in the P2 fraction of
cultured cortical neurons. Cortical neurons were exposed
to EtOH (50 mM for 60 minutes), followed by preparation
of P2 fractions. Western blot analysis of P2 fractions of
cortical neurons revealed that P2 fraction levels of GABAA
a1 were unchanged (A), whereas PKCg subunit levels
were increased by 78.1% 6 25.2% (B), PKA RIIa subunit
levels were increased by 35.5% 6 12.7% (C), and PKA
RIIb subunit levels were increased by 36.4%6 11.1% (D)
following ethanol exposure. Graphs show the mean 6 S.
E.M. of percent control optical density (OD) values
normalized to b-actin levels (n = 4–7 per group). *P ,
0.05 compared with vehicle (Student’s t test).
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exposure revealed that direct PKA activation resulted in a
rapid increase in potentiation by zolpidem that was sustained
over the course of the hour (n5 4; repeated-measures ANOVA,
f 5 22.03, P , 0.05, significantly increased at t 5 12–
60 minutes, Bonferroni post-test, P , 0.05), whereas current
amplitude was stable for currents evoked under control
conditions (Fig. 3).
Although ethanol alone did not significantly alter GABAA
a1 levels after 1 hour, coexposure of ethanol and the PKA
inhibitor Rp-cAMP decreased GABAA a1 membrane levels by
33% (n 5 4; one-way ANOVA, f 5 12.42, P , 0.05, Newman-
Keuls post-test, P , 0.05) (Fig. 4A). Ethanol, ethanol 1 Rp-
cAMP, or Rp-cAMP exposure had no effect on the GABA dose
response (Fig. 4B) or GABA-evoked current amplitude (Fig.
4C). Reduced membrane levels of a1 subunits corresponded
to reduced zolpidem potentiation of GABA responses in
ethanol1 Rp-cAMP–exposed cells (n5 6–11; one-way ANOVA,
f5 4.031,P, 0.05, Newman-Keuls post-test,P, 0.05) (Fig. 4, D
and E). Rp-cAMP exposure alone had no effect on GABAA a1
subunit levels or zolpidem potentiation.
Inhibition of PKC in the Presence of Ethanol Mimics
Direct PKA Activation. As ethanol is known to activate
PKC and inhibition of PKC prevents the GABAergic changes
seen after 4-hour ethanol exposure (Kumar et al., 2010;
Werner et al., 2011), P2 fractions levels of GABAA subunits
TABLE 1
Comparison of effects of ethanol at 1 and 4 hours on P2 fraction protein
levels
Data for 4-hour time point levels of GABAA a1 and PKCg are from Kumar et al.
(2010).
Protein 1-H Ethanol 4-H Ethanol
GABAA a1 109.4 6 9.6% ↓ 59.8 6 15.0%*
PKCg ↑ 178.1 6 21.0%* ↑ 152.3 6 19.0%*
PKA RIIa ↑ 135.5 6 12.7%* 97.1 6 5.3%
PKA RIIb ↑ 136.4 6 11.1%* 100.7 6 4.2%
*P , 0.05 compared with controls, Student’s t test.
Fig. 2. PKA activator Sp-cAMP increases GABAA a1 subunit expression and zolpidem potentiation in cultured cortical neurons. Cortical neurons were
exposed to vehicle or Sp-cAMP for 60minutes, followed by preparation of cellular fractions forWestern blot analysis or patch-clamp recording. Activation
of PKA increased GABAA receptor a1 subunit expression in the P2 fraction (58.4%6 13.7%) (A) and in the biotinylated surface protein fraction (50.5%6
18.5%) (B) compared with vehicle controls. There was a corresponding decrease in a1 subunit levels in the cytosolic fraction following Sp-cAMP (54.0%6
10.7%) (C). There was no effect of Sp-cAMP exposure on GABA dose response (control EC50 = 15.2 mM; Sp-cAMP EC50 = 17.5 mM) (D) or whole-cell
current amplitude (E) in response to 10 mMGABA. Sp-cAMP exposure significantly increased zolpidem potentiation relative to controls (78.1% 6 9.4%)
(F). (G) Representative GABA-evoked (10 mM) current traces for control and Sp-cAMP exposure with and without 100 nM zolpidem. Data are presented
as mean 6 S.E.M. Representative blots are shown. *P , 0.05, Student’s t test; n = 6–18 per group.
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were measured following 1-hour ethanol exposure in the pre-
sence of the PKC inhibitor CalC (0.3 mM). Coexposure of
ethanol and CalC uncovered effects not normally observed at
1 hour. GABAA a1 membrane levels were increased 56% (n 5
6; one-way ANOVA, f5 11.91, P, 0.05, Newman-Keuls post-
test, P , 0.05) (Fig. 5A).
The regulation of GABAA receptor a1 subunit expression in
the P2 fraction was corroborated by the effects of ethanol plus
kinase inhibitors on GABA-evoked currents (compare Figs. 3
and 5, B and C). Ethanol (50 mM) was applied via the extra-
cellular solution at the start of the time course, while CalC or
Rp-cAMP was in the patch pipette. Currents evoked by GABA
and zolpidem over the course of 1 hour were compared with
currents averaged for 10 minutes prior to drug exposure.
Current amplitudes were stable prior to application of ethanol
and kinase inhibitors (Fig. 5). Current amplitude was not
significantly altered in the presence of ethanol alone (Fig. 5, B
and C). Coapplication of ethanol 1 CalC, however, rapidly in-
creased the current amplitude produced by GABA 1 zolpi-
dem, mimicking the results of direct PKA activation shown
above (n 5 3; repeated-measures ANOVA, f 5 3.863, signif-
icantly increased at t 5 14–60 minutes, Bonferroni post-test,
P , 0.05). Conversely, coapplication of ethanol 1 Rp-cAMP
resulted in a rapid decrease in current amplitude that was
also sustained for the duration of 1 hour (n 5 3; repeated-
measures ANOVA, f 5 11.10, significantly decreased at t 5
8–60 minutes, Bonferroni post-test, P , 0.05).
PKA Activation by Ethanol Regulates Zolpidem
Modulation of mIPSC Decay t2. As ethanol exposure has
been shown to alter mIPSC decay kinetics, which is related to
changes in GABAA receptor subunit expression (Liang et al.,
2006; Fleming et al., 2009; Werner et al., 2011), recordings of
mIPSCs were made to further investigate the functional con-
sequences of ethanol activation of PKA on synaptic GABAA
receptor signaling. Although there appeared to be a slight
shift in the mIPSC decay kinetics suggestive of an altered
synaptic GABAA receptor expression profile, there was not a
significant direct effect of 1 hour ethanol and/or PKA mod-
ulation on GABA mIPSC kinetics (Fig. 6A; Table 2). To fur-
ther investigate the potential for receptor subtype–specific
effects on mIPSCs, recordings were also made in the presence
of 100 nM zolpidem. Under control conditions zolpidem in-
creased decay t2 as expected (comparison of control with and
without zolpidem, P , 0.05, Student’s t test). Further, decay
t2 in the presence of zolpidem (Fig. 6B; Table 2) was decreased
after ethanol1 Rp-cAMP exposure (24.7%6 3.2%; n5 6) and
increased after Sp-cAMP exposure (68.8% 6 9.0%; n 5 6)
relative to controls (46.1% 6 3.7%; n 5 8; one-way ANOVA,
f5 9.673, P, 0.05, Newman-Keuls post-test, P, 0.05 for both
comparisons). No other mIPSC characteristics were altered
in the presence of zolpidem following modulation of PKA
activity (Table 2).
Discussion
The present results demonstrate that ethanol activation of
PKA plays an active role in GABAA receptor trafficking and
function. PKA activation results in an increase in GABAA a1
subunit expression in P2 and biotinylated fractions of surface
receptors in cultured cortical neurons. The finding that these
alterations corresponded to functional changes in zolpidem
enhancement of GABA responses corroborates this conclu-
sion. Additionally, our results highly implicate oppositional
roles of PKA and PKC in GABAA receptor regulation. Ethanol
is known to activate both PKA and PKC pathways, and our
past results coupled with the present studies indicate that
such changes in activity are accompanied by increases in PKA
and PKC abundance in the P2 fraction. We demonstrate that
inhibiting the activity of either kinase pathway in the
presence of ethanol results in GABAA a1 subunit alterations
that are dependent on the sum of the activity of these protein
kinase pathways. Specifically, inhibition of PKC in the pres-
ence of ethanol results in increased GABAA a1 surface ex-
pression, similar to that observed following exposure to PKA
activators alone. Furthermore, a decrease in GABAA re-
ceptor a1 subunit levels similar to that found in models of
ethanol dependence in vivo (Devaud et al., 1997; Cagetti
et al., 2003; Liang et al., 2004) or 4-hour ethanol exposure in
vitro (Kumar et al., 2010; Werner et al., 2011) could be
observed after 1-hour ethanol exposure in the presence of
a PKA antagonist.
The results suggest that ethanol activates at least two op-
posing pathways in the cerebral cortex: PKAandPKC.Whereas
PKCg activation results in decreased GABAA receptor a1
subunit (Kumar et al., 2010), PKA appears to counteract these
changes. Such opposition is consistent with previous studies
that have found an apparent antagonistic role of PKA and
PKC working in other areas of the central nervous system
(Vaello et al., 1994; Brandon et al., 2000; Grey and Chang,
Fig. 3. PKA activation produces rapid increases in zolpidem potentiation
of GABA responses. Whole-cell currents were evoked by application of
GABA (1 mM) and zolpidem (100 nM) at 2-minute intervals over the course
of 1 hour with vehicle or Sp-cAMP (50 mM) exposure. (A) Currents evoked
in Sp-cAMP–exposed cells were increased from 12–60 minutes (repeated-
measures ANOVA, f = 3.648, P , 0.05, Bonferroni post-test), whereas
control (Ctrl) cells were unaffected. Data are presented as mean6 S.E.M.;
n = 3–4. (B) Representative whole-cell current traces elicited by GABA and
zolpidem before (t = 0) and after (t = 60 minutes) exposure.
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2011). The data further suggest that these kinases are under
time-dependent regulation by ethanol. Although PKA and
PKC are both active at 1 hour of ethanol exposure, no overall
change in GABAA a1 subunit expression is observed. By 4
hours, however, PKA activity has returned to baseline while
PKC remains active, and trafficking of GABAA a1 receptors
is observed (Kumar et al., 2010; Werner et al., 2011). An in-
crease in PKA translocation to the P2 synaptosomal region is
consistent with ethanol-induced activation of PKA observed in
other cellular systems (Diamond and Gordon, 1997). Although
the exact role of increased PKA subunits in the synaptosomal
region is unclear, the effects of direct activation by
Sp-cAMP, or inactivation by Rp-cAMP in the presence of
ethanol, would suggest that ethanol is increasing overall
catalytic activity by PKA. Future studies might investigate
the specific phosphorylation states regulating trafficking of
a1 subunits by the oppositional PKA and PKC activation by
ethanol.
The present results extend several recent studies charac-
terizing altered GABAA regulation following ethanol expo-
sure. These alterations include a shift in the normal synaptic
and extrasynaptic GABAA receptor trafficking. Studies in
the hippocampus have found a decrease in synaptic a1 and
extrasynaptic a4d receptors, and a corresponding increase in
synaptic a4 GABAA receptors, following both acute (Liang
et al., 2007) and chronic (Cagetti et al., 2003; Liang et al., 2004)
Fig. 4. PKA inhibitor RP-cAMP decreases GABAA a1 expression and zolpidem potentiation in the presence of ethanol. Neurons were exposed to vehicle,
ethanol (EtOH) (50 mM), EtOH with Rp-cAMP (50 mM), or Rp-cAMP alone for 60 minutes, followed by preparation of P2 fractions for Western blot
analysis or patch-clamp recording. EtOH or Rp-cAMP exposure alone did not alter GABAA receptor a1 subunit expression; however, EtOH exposure in
the presence of the PKA inhibitor Rp-cAMP decreased GABAA receptor a1 subunit expression by 33% (one-way ANOVA, f = 12.42, P , 0.05, Newman-
Keuls post-test) (A). There was no effect of drug exposure on GABA dose response (not all dose-response curves shown for visual simplicity; EtOH +
Rp-cAMP EC50 = 16.4 mM) (B) or whole-cell current amplitude (C) in response to 10 mM GABA. (D) EtOH + Rp-cAMP decreased zolpidem potentiation
(one-way ANOVA, f = 4.031, P , 0.05, Newman-Keuls post-test) of GABA-evoked currents compared with vehicle control, whereas EtOH or Rp-cAMP
had no effect. (E) Representative GABA-evoked (10 mM) current traces for control and EtOH + Rp-cAMP exposure with and without 100 nM zolpidem.
Data are presented as mean 6 S.E.M. Optical density (OD) values normalized to b-actin. Representative blots are shown. *P , 0.05, one-way ANOVA,
Newman-Keuls post-test; n = 3–21 per group.
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ethanol exposure, thereby producing an overall decrease in
GABAergic inhibition and increasing central nervous system
hyperexcitability. The present results suggest that these
processes are conserved in the cerebral cortex as well (Kumar
et al., 2010; Werner et al., 2011). The lack of an effect of brief
(1-hour) ethanol exposure on GABAA a1 receptors in the
present study is consistent with prior reports in cerebral
cortex and in cultured cortical neurons (Kumar et al., 2003,
Fig. 5. PKA and PKC activation by ethanol (EtOH) pro-
duces opposing effects on GABAA a1 expression and
zolpidem potentiation of GABA responses. (A) Neurons
were exposed to vehicle, EtOH (50 mM), or EtOH with CalC
(0.3 mM) for 60 minutes, followed by preparation of P2
fractions andWestern blot analysis. EtOH or CalC exposure
alone did not alter GABAA receptor a1 subunit expression;
however, EtOH exposure in the presence of the PKC inhib-
itor CalC increased GABAA receptor a1 subunit expression
by 56% (one-way ANOVA, f = 11.91, P , 0.05, Newman-
Keuls post-hoc test). (B and C) Whole-cell currents were
evoked by application of GABA (1 mM) and zolpidem (100
nM) at 2-minute intervals over the course of 1 hour during
exposure to EtOH (50 mM), EtOH and Rp-cAMP (50 mM), or
EtOH and CalC (3 mM). Currents were stable for the 10-
minute period prior to bath application of EtOH and during
diffusion of CalC or Rp-cAMP via the recording pipette.
Currents evoked by EtOH + CalC were significantly in-
creased from 14–60 minutes (repeated-measures ANOVA,
f = 3.863, P, 0.05, Bonferroni post-test). Currents evoked by
EtOH + Rp-cAMP were significantly decreased at 8–60
minutes (repeated-measures ANOVA, f = 11.10, P , 0.01,
Bonferroni post-test). (C) Representative whole-cell current
traces elicited by GABA and zolpidem before (t = 0) and after
(t = 60 minutes) EtOH and drug exposure. Data are pre-
sented as mean 6 S.E.M.; n = 3–6 per group.
Fig. 6. Ethanol (EtOH) and PKA modu-
lation of GABAA mIPSC decay kinetics
in the presence of zolpidem. Recordings
were made in the presence of tetrodotoxin,
6-cyno-7-nitroquinoxaline-2,3-dione, and
D-2-amino-5-phosphonopentanoic acid to
pharmacologically isolate GABA mIPSCs.
Representative averaged mIPSC traces,
following exposure to vehicle (control) or
drug and standardized for peak ampli-
tude, are shown. (A) Representative con-
trol (no zolpidem) traces following control,
EtOH, Sp-cAMP, or EtOH + Rp-cAMP
exposure. (B) Representative traces in the
presence of zolpidem (100 nM) following
control, Sp-cAMP, or EtOH + Rp-cAMP
exposure. Summarized data are shown in
Table 2.
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2010); however, more rapid effects of ethanol have been
observed in rat hippocampus (Liang et al., 2007), suggest-
ing that the time course of ethanol regulation of GABAA
receptors may differ across brain regions. We have pre-
viously shown that ethanol activation of PKC differs in rat
cortex and hippocampus (Kumar et al., 2006). Further
studies are needed to determine if regional differences in
the time course of ethanol regulation of GABAA receptors
are secondary to regional differences in ethanol activation
of protein kinases.
Previous studies have shown that PKA and PKC activation
have direct effects on GABA responses that were not observed
in the present study (Kittler and Moss, 2003). This is likely
due to the use of different model systems and the fact that we
focused on the GABAA a1 receptors in cerebral cortex that are
sensitive to 100 nM zolpidem. To isolate effects on these
receptors in cultured neurons, we used an IC10 concentration
of GABA. It is quite possible that effects of PKA or PKC
inhibitionmay have been observed at higher concentrations of
GABA; however, such an experiment would involve actions at
additional receptor subtypes. Although effects of PKA on
GABAA receptor function have been previously observed
(Brandon et al., 2003; Lilly et al., 2003), this is the first
evidence that PKA specifically regulates trafficking and
function of zolpidem-sensitive GABAA a1 receptors. The
observation that inhibition of PKA or PKC alone had no effect
on a1 receptor abundance or function, however, suggests that
these kinases do not constitutively regulate GABAA a1 re-
ceptors. Rather, these pathways may only become active
regulators of GABAergic inhibition following physiological
insults such as ethanol exposure or processes associated with
epileptogenesis (Gonzalez and Brooks-Kayal, 2011).
Although our present results demonstrate modulation of
GABAA receptor a1 subunit abundance by PKA in vitro, our
previous results suggest the same processes occur in vivo
(Kumar et al., 2012). Recently, we found that GABAA a1 levels
in rat cerebral cortex were increased following an acute
ethanol injection, concurrent with an increase in PKA,
whereas PKC was unchanged. Further, behavioral studies
have well established that PKA is a key mediator of ethanol
sensitivity. Infusion of Sp-cAMP into the lateral ventricles
prior to systemic ethanol administration increased the du-
ration of loss of righting reflex (Kumar et al., 2012). Con-
versely, inhibition of PKA prior to ethanol administration
decreased loss of righting reflex duration (Lai et al., 2007) and
withdrawal-induced anxiety (Pandey et al., 2003). Studies
utilizing mutant mouse lines with reduced PKA activity mimic
results found with pharmacological inhibition of PKA (Thiele
et al., 2000; Naassila et al., 2002; Kim et al., 2011). The precise
role of PKA in mediating these behaviors is complex,
however, as some studies have found increased ethanol
sensitivity in animals with diminished PKA activity (Wand
et al., 2001; Yang et al., 2003; Maas et al., 2005). Although
the precise role remains equivocal, collectively these studies
clearly establish the importance of PKA activation in medi-
ating the behavioral effects of ethanol, potentially through
GABAA receptor regulation. The present results underscore
the clinical relevance of understanding the role of PKA in
modulating the effects of ethanol for the development of drugs
for the treatment of alcoholism.
The relatively rapid time course over which changes in
zolpidem potentiation were observed suggests a posttransla-
tional mechanism of GABAA receptor regulation (Brandon
et al., 2002). Previous studies in cultured cerebral cortical
neurons have found changes in GABAA receptor activity via
phosphorylation and dephosphorylation to be due entirely
to changes in channel gating and conductance rather than
channel number (Brandon et al., 2000). The fact that the func-
tional changes were observed prior to alterations in surface
receptor expression suggest that multiple mechanisms of
GABA regulation may be involved, including both direct
effects on channel conductance as well as receptor traffick-
ing. Further studies investigating single-channel conduc-
tance states and utilizing phosphorylation state–dependent
antibodies will help to elucidate these mechanisms. Addi-
tionally, the observation that whole-cell GABA-evoked cur-
rent amplitude was unchanged would suggest bidirectional
regulation of GABA receptor subtypes by PKA, as well as
ethanol. Thus, whereas PKA activation leads to increased
surface expression of GABAA a1 receptors, there is likely a
concurrent decrease in other subtypes. Previous studies have
observed bidirectional regulation of synaptic GABAA a1– and
a4–containing receptors by PKCg (Kumar et al., 2010; Werner
et al., 2011), and studies are currently under way to investigate
bidirectional regulation of GABAA a4 receptors by PKA.
Overall, the present study elucidates a novel role for PKA
in the subcellular pathways mediating the effects of ethanol.
Although PKC and PKA play important roles in altered
GABAA receptor trafficking following ethanol exposure, it is
possible that other kinases or phosphatases are also active.
In particular, ethanol-induced adaptations in other brain
regions may be governed by different subcellular mecha-
nisms, which could, in part, account for some of the brain
region–specific effects of ethanol. This area requires further
TABLE 2
GABAA mIPSC kinetics following exposure to PKA modulators and ethanol
Measure Control Ethanol Ethanol + Rp-cAMP Sp-cAMP
Rise time (ms) 3.6 6 1.5 1.2 6 0.8 4.0 6 1.5 1.3 6 0.9
Decay 90–37% (ms) 14.4 6 2.6 21.7 6 1.6 14.9 6 2.2 16.7 6 2.2
Half-width (ms) 12.6 6 2.5 20.1 6 0.7 14.5 6 3.2 16.4 6 2.0
Amplitude (pA) 25.3 6 0.8 23.4 6 1.0 23.2 6 1.1 21.8 6 1.8
Frequency (Hz) 2.6 6 0.9 1.6 6 0.2 1.6 6 0.5 1.5 6 0.3
Decay t1 (ms) 13.2 6 2.4 18.3 6 2.0 15.0 6 3.2 16.8 6 1.7
Decay t2 (ms) 31.0 6 6.4 36.6 6 5.8 26.3 6 2.5 45.6 6 10
Decay t2 (ms) with zolpidem 46.1 6 3.7** 46.2 6 6.0 24.7 6 3.2* 68.8 6 9.0*
n 8 6 6 6
** P , 0.05 compared with control decay t2 (without zolpidem), Student’s t test; *P, 0.05 compared with controls with
zolpidem, one-way ANOVA, Newman-Keuls post-test.
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study to fully elucidate the physiology of ethanol intoxication
and withdrawal. Nonetheless, the current results suggest
that PKA activation may delay some ethanol-induced adap-
tations in GABAergic signaling. Additionally, PKA may pro-
vide a promising target for the development of drugs aimed at
restoring normal GABAA receptor functioning for the treat-
ment of multiple pathologies involving similar GABAA re-
ceptor adaptations, including alcohol dependence, epilepsies,
and benzodiazepine abuse.
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